PMID- 22262311 OWN - NLM STAT- MEDLINE DCOM- 20121127 LR - 20120911 IS - 1096-9896 (Electronic) IS - 0022-3417 (Linking) VI - 228 IP - 2 DP - 2012 Oct TI - Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness. PG - 181-92 LID - 10.1002/path.3993 [doi] AB - A loss of balance between cell membrane-associated proteases and their inhibitors may underlie cancer invasion and metastasis. We analysed the roles of a membrane- associated serine protease inhibitor, HAI-1, in oral squamous cell carcinoma (OSCC). While membranous HAI-1 was widely observed in cancer cells of human OSCC tissues, this was significantly reduced at the infiltrative invasion front. In vitro, HAI-1 was detected in all eight OSCC cell lines examined, in which its cognate membrane protease, matriptase was also expressed. HAI-1 expression knock-down (KD) in OSCC lines, SAS and HSC-3, reduced the growth of both lines in vitro but significantly enhanced SAS tumourigenicity in vivo, which was accompanied by histological changes suggestive of the epithelial-mesenchymal transition. Both HAI-1-KD lines also exhibited significantly enhanced migratory capability, and membrane-associated but not truncated HAI-1 was required to rescue this phenotype. Other OSCC lines (HSC-2, Sa3, Ca9-22) also showed enhanced migration in response to HAI-1 KD. The enhanced migration is partly attributed to dysregulation of matriptase, as simultaneous matriptase KD alleviated the migration of HAI-1-KD cells. HAI-1 deficiency also altered the expression of CD24, S100A4, CCND2 and DUSP6, all of which are involved in tumour progression. While matriptase was involved in the increased CD24 expression associated with HAI-1 deficiency, the protease appeared to be not responsible for the altered expression of other genes. Therefore, a matriptase-independent mechanism for the invasiveness associated with HAI-1 KD is also present. Together, these observations suggest that HAI-1 has a crucial suppressive role in OSCC cell invasiveness. CI - Copyright (c) 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. FAU - Baba, Takashi AU - Baba T AD - Section of Oncopathology and Regenerative Biology, Department of Pathology, University of Miyazaki, Japan. FAU - Kawaguchi, Makiko AU - Kawaguchi M FAU - Fukushima, Tsuyoshi AU - Fukushima T FAU - Sato, Yuko AU - Sato Y FAU - Orikawa, Hiroshi AU - Orikawa H FAU - Yorita, Kenji AU - Yorita K FAU - Tanaka, Hiroyuki AU - Tanaka H FAU - Lin, Chen-Yong AU - Lin CY FAU - Sakoda, Sumio AU - Sakoda S FAU - Kataoka, Hiroaki AU - Kataoka H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120418 PL - England TA - J Pathol JT - The Journal of pathology JID - 0204634 RN - 0 (Proteinase Inhibitory Proteins, Secretory) RN - 0 (SPINT1 protein, human) RN - EC 3.4.21.- (Serine Endopeptidases) RN - EC 3.4.21.- (matriptase) SB - IM MH - Animals MH - Carcinoma, Squamous Cell/metabolism/*secondary MH - Cell Line, Tumor MH - Cell Movement MH - Cell Proliferation MH - Female MH - Gene Expression MH - Gene Expression Profiling MH - Gene Knockdown Techniques MH - Humans MH - Lymph Nodes/pathology MH - Lymphatic Metastasis MH - Male MH - Mice MH - Mice, Inbred BALB C MH - Mice, Nude MH - Middle Aged MH - Mouth Neoplasms/metabolism/*pathology MH - Neoplasm Invasiveness MH - Neoplasm Staging MH - Proteinase Inhibitory Proteins, Secretory/*deficiency MH - Serine Endopeptidases/genetics/metabolism EDAT- 2012/01/21 06:00 MHDA- 2012/12/10 06:00 CRDT- 2012/01/21 06:00 PHST- 2011/09/27 00:00 [received] PHST- 2011/12/29 00:00 [revised] PHST- 2012/01/12 00:00 [accepted] PHST- 2012/01/21 06:00 [entrez] PHST- 2012/01/21 06:00 [pubmed] PHST- 2012/12/10 06:00 [medline] AID - 10.1002/path.3993 [doi] PST - ppublish SO - J Pathol. 2012 Oct;228(2):181-92. doi: 10.1002/path.3993. Epub 2012 Apr 18.